Introduction
Gynecomastia is diagnosed by combining a careful clinical evaluation with selective testing when needed. In medical terms, it refers to the benign enlargement of male breast tissue caused by a shift in the balance between estrogenic and androgenic effects at the breast. Because breast enlargement in males can also result from fat accumulation, medication effects, endocrine disease, or, less commonly, breast cancer, accurate diagnosis matters. The goal is not only to confirm that true glandular breast tissue is present, but also to identify any underlying cause that may require treatment.
In many cases, the diagnosis is made primarily through history and physical examination. Tests are used when the presentation is atypical, when there are warning signs, or when the clinician suspects an underlying hormonal, systemic, or structural problem. The diagnostic process therefore focuses on two questions: is this true gynecomastia, and if so, why is it occurring?
Recognizing Possible Signs of the Condition
Gynecomastia is usually first suspected when a male patient notices a firm or rubbery enlargement beneath the nipple and areola. This tissue often feels like a discrete mound or disk centered directly behind the nipple rather than a diffuse soft increase in chest fat. It may be present on one side or both, and the size can range from subtle fullness to a more obvious breast contour.
Some patients report tenderness or mild pain, particularly in the early or active phase of glandular growth. This discomfort reflects proliferation of breast ductal and stromal tissue, which can be more biologically active before the tissue becomes stable or fibrotic. Nipple sensitivity may also occur. In long-standing cases, the area may be non-tender and firm.
Although symptoms may be limited to breast enlargement, clinicians also look for clues that point to a broader endocrine or systemic disorder. Reduced body hair, decreased libido, erectile dysfunction, testicular changes, fatigue, weight change, thyroid symptoms, liver disease signs, or a history of new medication use can all support the possibility that gynecomastia is part of a wider medical issue rather than an isolated breast finding.
Medical History and Physical Examination
The diagnostic process begins with a detailed history. A clinician will ask when the breast enlargement started, whether it progressed rapidly or slowly, whether it is painful, and whether it affects one side or both. The time course is important because recent onset may suggest an active hormonal trigger, while long-standing enlargement often indicates more established tissue change. Age also matters, since temporary gynecomastia can occur in newborns, adolescents, and older men due to physiologic hormonal shifts.
Medication review is a major part of the history. Many drugs can alter hormone balance or directly promote breast tissue growth, including certain antiandrogens, anabolic steroids, some psychiatric medications, spironolactone, cimetidine, and others. Alcohol, cannabis use, and exposure to exogenous estrogens or hormone-containing products are also relevant. The clinician will typically ask about prior surgeries, testicular problems, fertility issues, chronic illness, and symptoms of liver, kidney, or thyroid disease.
During the physical examination, the healthcare professional confirms whether the enlargement represents glandular tissue or fat. True gynecomastia typically feels like a firm, mobile, rubbery disk centered under the nipple. In contrast, pseudogynecomastia is mostly adipose tissue and feels softer and less discrete. The examiner also checks for asymmetry, nipple discharge, skin dimpling, retraction, or a hard irregular mass, which may suggest another diagnosis.
The examination usually extends beyond the chest. The testes are assessed for size, texture, masses, or signs of atrophy, because impaired testicular hormone production or estrogen-secreting tumors can present with breast enlargement. The clinician may look for signs of androgen deficiency, hyperthyroidism, chronic liver disease, or other systemic conditions. In adolescents, the exam helps distinguish physiologic pubertal development from abnormal or persistent enlargement.
Diagnostic Tests Used for Gynecomastia
Not every patient requires extensive testing. In a typical adolescent with symmetrical, mild breast enlargement and no concerning findings, a clinician may diagnose pubertal gynecomastia clinically and observe over time. Testing becomes more important when the onset is unusual, the enlargement is progressive, unilateral, severe, painful, associated with other abnormalities, or unexplained by age or medications.
Laboratory tests are used to look for hormonal or systemic causes. Common studies include total testosterone, free testosterone in selected cases, estradiol, luteinizing hormone, follicle-stimulating hormone, prolactin, thyroid-stimulating hormone, and human chorionic gonadotropin. These tests help determine whether there is hypogonadism, increased estrogen production, pituitary dysfunction, thyroid disease, or a tumor producing hCG or estrogen-like effects. Liver function tests and kidney function tests are often ordered because liver disease and renal failure can alter hormone metabolism and contribute to gynecomastia. If clinical suspicion is high, clinicians may also check markers related to adrenal or testicular disease.
Imaging tests are used selectively. Breast ultrasound can help distinguish glandular tissue from fat and can characterize a palpable mass if the physical exam is not definitive. Mammography is more commonly used when the presentation is atypical or when breast cancer must be excluded, especially in older patients or when there is a unilateral firm mass, nipple retraction, or suspicious discharge. Testicular ultrasound may be ordered if there is a testicular mass, asymmetry, infertility, or abnormal hormone results suggesting a source of excess estrogen or hCG. In some cases, imaging of the adrenal glands, chest, or pituitary region may be considered when labs indicate a possible endocrine tumor or central hormonal disorder.
Functional tests are not used to diagnose gynecomastia itself, but they may be important when evaluating the underlying reason for hormone imbalance. For example, thyroid testing assesses whether hyperthyroidism is increasing estrogen effects indirectly. Gonadotropin and testosterone measurements help evaluate testicular function and the hypothalamic-pituitary-gonadal axis. If delayed puberty or hypogonadism is suspected, additional endocrine evaluation may be required to determine whether the body is producing insufficient testosterone or whether the tissues are not responding normally to hormonal signals.
Tissue examination is rarely needed, but it can be decisive when the diagnosis is uncertain. If a breast mass has suspicious features or if cancer cannot be ruled out by exam and imaging, a biopsy may be performed. Histologic examination can show the proliferative ductal and stromal changes typical of gynecomastia. This differs from male breast carcinoma, which has malignant cellular features and invasive growth patterns. Tissue examination is reserved for cases in which the usual clinical pattern does not fit benign glandular enlargement.
Interpreting Diagnostic Results
Doctors interpret results by combining the clinical pattern with test findings rather than relying on any single measurement. A classic exam showing a symmetric, rubbery subareolar disk in a patient with a known medication trigger may be enough to confirm gynecomastia clinically. If laboratory studies are normal and no red flags are present, the diagnosis is usually straightforward.
Abnormal hormone results help identify the mechanism. Low testosterone with elevated luteinizing hormone may point to primary testicular failure. Low testosterone with low or inappropriately normal luteinizing hormone can suggest secondary hypogonadism from hypothalamic or pituitary disease. Elevated estradiol or hCG raises concern for estrogen-producing or hCG-secreting tumors. Abnormal thyroid studies may reveal hyperthyroidism, while liver or kidney abnormalities suggest impaired hormone metabolism or chronic systemic disease.
Imaging findings are interpreted in context. A breast study showing diffuse glandular tissue supports gynecomastia, while a discrete suspicious lesion may require biopsy. Testicular ultrasound abnormalities can explain the breast enlargement by identifying a hormone-producing tumor or other gonadal pathology. The diagnostic conclusion is therefore based on whether the collected data support a benign proliferation of male breast glandular tissue and whether a treatable underlying driver has been found.
Conditions That May Need to Be Distinguished
Several conditions can resemble gynecomastia and must be separated from it. The most common is pseudogynecomastia, which is enlargement from fatty tissue rather than glandular proliferation. This is more common in obesity and feels softer and less discrete on examination. Identifying the tissue type is important because the approach to weight-related chest fullness differs from that for hormone-driven glandular enlargement.
Male breast cancer is uncommon but must be considered when the mass is unilateral, firm, fixed, eccentric to the nipple, or associated with skin changes or nipple discharge. Unlike gynecomastia, which is usually centered beneath the areola and often symmetric, cancer tends to present as a more suspicious localized lesion. Imaging and biopsy may be needed when the exam does not clearly fit benign gynecomastia.
Other endocrine disorders can also mimic or contribute to the same presentation. Testicular tumors, hypogonadism, hyperthyroidism, pituitary disease, chronic liver disease, chronic kidney disease, and medication-induced breast enlargement are all part of the differential diagnosis. In adolescents, normal pubertal breast development must be distinguished from persistent or rapidly progressive enlargement. The key distinction is whether the tissue change reflects a physiologic hormonal transition or an abnormal process requiring investigation.
Factors That Influence Diagnosis
Several patient-specific factors shape how aggressively clinicians evaluate gynecomastia. Age is one of the most important. Newborns may have transient breast enlargement from maternal hormones, adolescents may develop temporary pubertal gynecomastia, and older men are more likely to have age-related hormonal decline, medication exposure, or chronic disease. These age-related patterns influence whether observation or broader testing is appropriate.
Severity and duration also matter. Mild, recent, and symmetric enlargement is more likely to be benign and transient, while rapidly enlarging, painful, or unilateral masses deserve closer evaluation. Long-standing gynecomastia may become fibrotic and less tender, but chronicity does not exclude a treatable cause if the underlying hormone imbalance persists.
Associated medical conditions can broaden the workup. Obesity can obscure the distinction between fatty tissue and glandular enlargement. Liver disease, renal disease, thyroid disease, infertility, sexual dysfunction, and testicular abnormalities all raise the likelihood of a systemic or endocrine cause. Drug history is equally important because medication-induced gynecomastia is common and often reversible when the triggering agent is removed. The diagnostic strategy is therefore individualized rather than uniform.
Conclusion
Gynecomastia is diagnosed through a structured medical evaluation that begins with history and physical examination and expands to testing when the presentation is atypical or unexplained. Clinicians look for true subareolar glandular tissue, assess symptoms and medication exposures, and examine for signs of hormonal or systemic disease. Laboratory studies can identify endocrine imbalance or organ dysfunction, imaging can clarify uncertain breast findings or search for tumors, and tissue examination is used when cancer or another mass cannot be excluded.
Accurate diagnosis depends on distinguishing glandular enlargement from fat deposition and on identifying whether the breast change is isolated or secondary to another disorder. This combination of clinical reasoning and targeted testing allows doctors to confirm gynecomastia, rule out more serious conditions, and determine whether an underlying cause is present.